Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 20/20 | 0.76 |
| ▸ | KCNH2 | Q12809 | 9/20 | 0.76 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL943489 | 0.87 | BACE1 (1.00) | BACE1KCNH2BACE2 | |
| SCHEMBL946602 | 0.86 | BACE1 (0.57) | BACE1KCNH2BACE2 | |
| SCHEMBL946218 | 0.81 | BACE1 (0.49) | BACE1KCNH2BACE2 | |
| SCHEMBL1075789 | 0.73 | BACE1 (0.74) | BACE1KCNH2BACE2 | |
| SCHEMBL932037 | 0.71 | BACE1 (0.68) | BACE1KCNH2BACE2 | |
| SCHEMBL6891914 | 0.70 | BACE1 (0.71) | BACE1KCNH2BACE2 | |
| SCHEMBL932637 | 0.70 | BACE1 (0.86) | BACE1KCNH2BACE2 | |
| SCHEMBL945501 | 0.70 | BACE1 (0.47) | BACE1KCNH2BACE2 | |
| SCHEMBL931802 | 0.69 | BACE1 (0.38) | BACE1KCNH2BACE2 | |
| SCHEMBL931852 | 0.64 | BACE1 (0.49) | BACE1KCNH2BACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011002408-A1 | NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA | ASTRAZENECA AB (SE) | 2011-01-06 | — | — | WO | disclosed |
| WO-2011002408-A1 | NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA | ASTRAZENECA AB (SE) | 2011-01-06 | — | — | WO | disclosed |